Tomoo Yamazaki

1.1k total citations
59 papers, 753 citations indexed

About

Tomoo Yamazaki is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tomoo Yamazaki has authored 59 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 36 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Tomoo Yamazaki's work include Liver Disease Diagnosis and Treatment (37 papers), Liver Disease and Transplantation (13 papers) and Liver Diseases and Immunity (13 papers). Tomoo Yamazaki is often cited by papers focused on Liver Disease Diagnosis and Treatment (37 papers), Liver Disease and Transplantation (13 papers) and Liver Diseases and Immunity (13 papers). Tomoo Yamazaki collaborates with scholars based in Japan, United States and India. Tomoo Yamazaki's co-authors include Takeji Umemura, Satoru Joshita, Naoyuki Fujimori, Akihiro Matsumoto, Eiji Tanaka, Ayumi Sugiura, Michiharu Komatsu, Takefumi Kimura, Soichiro Shibata and Naoki Tanaka and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tomoo Yamazaki

56 papers receiving 748 citations

Peers

Tomoo Yamazaki

EPIDE

HEPAT

SURGE

EDM

Kazuyuki Ohata Japan

Nobuyuki Torii Japan

Manabu Daikoku Japan

Alip Ghosh India

Mengfei Liu United States

P. Sanz-Cameno Spain

N. Guenther Germany

June Sung Lee South Korea

Sara Cmet Italy

Noam Peleg Israel

Kazuyuki Ohata Japan

Tomoo Yamazaki

538 ×1.0

EPIDE

382 ×0.9

HEPAT

101 ×0.6

121 ×0.9

SURGE

103 ×1.1

EDM

Citations per year, relative to Tomoo Yamazaki Tomoo Yamazaki (= 1×) peers Kazuyuki Ohata

Countries citing papers authored by Tomoo Yamazaki

Since Specialization

Citations

This map shows the geographic impact of Tomoo Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoo Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoo Yamazaki more than expected).

Fields of papers citing papers by Tomoo Yamazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoo Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoo Yamazaki. The network helps show where Tomoo Yamazaki may publish in the future.

Co-authorship network of co-authors of Tomoo Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoo Yamazaki. A scholar is included among the top collaborators of Tomoo Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoo Yamazaki. Tomoo Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabré, Noemí, Marcos F. Fondevila, Tomoo Yamazaki, et al.. (2025). Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease. Journal of Clinical Investigation. 135(13). 3 indexed citations

Joshita, Satoru, Tomoo Yamazaki, Hiroyuki Kobayashi, et al.. (2023). HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population. Human Immunology. 84(8). 401–407. 2 indexed citations

Kimura, Takefumi, Tomoo Yamazaki, Hamim Zafar, et al.. (2023). Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease. Liver International. 44(2). 483–496. 12 indexed citations

Nakazawa, Hideyuki, Koji Igarashi, Tomoo Yamazaki, et al.. (2022). A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis. Clinical Lymphoma Myeloma & Leukemia. 23(2). e117–e124.

Fujimori, Naoyuki, Takefumi Kimura, Naoki Tanaka, et al.. (2022). 2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease. Hepatology Research. 52(4). 352–363. 9 indexed citations

Kimura, Takefumi, Naoki Tanaka, Tomoo Yamazaki, et al.. (2022). Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD. Biomedicines. 10(11). 2806–2806. 8 indexed citations

Joshita, Satoru, Yūki Yamashita, Toru Okamoto, et al.. (2021). Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct‐acting antivirals. Hepatology Research. 51(7). 758–766. 3 indexed citations

Joshita, Satoru, Kazuhiro Kimura, Hirohiko Motoki, et al.. (2021). Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. PLoS ONE. 16(4). e0249435–e0249435. 1 indexed citations

Umemura, Takeji, Satoru Joshita, Hiromi Saito, et al.. (2021). Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients. Cancers. 13(13). 3267–3267. 8 indexed citations

10.

Yamashita, Yūki, Satoru Joshita, Ayumi Sugiura, et al.. (2021). aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C. Hepatology Research. 51(9). 933–942. 15 indexed citations

11.

Yamashita, Yūki, Satoru Joshita, Hiroyuki Kobayashi, et al.. (2021). Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature. Medicina. 57(3). 280–280. 6 indexed citations

12.

Yamazaki, Tomoo, Mayumi Sugita, J. Martinet, et al.. (2020). Boosting CAR T Cell Expansion and Therapeutic Activity with Low-dose Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). S158–S159. 5 indexed citations

13.

Joshita, Satoru, Takeji Umemura, Yūki Yamashita, et al.. (2019). Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis. Hepatology Research. 49(10). 1236–1243. 29 indexed citations

14.

Joshita, Satoru, Yūki Yamashita, Ayumi Sugiura, et al.. (2019). Clinical utility of FibroScan as a non‐invasive diagnostic test for primary biliary cholangitis. Journal of Gastroenterology and Hepatology. 35(7). 1208–1214. 22 indexed citations

15.

Joshita, Satoru, Ayumi Sugiura, Takeji Umemura, et al.. (2019). Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection. JGH Open. 4(4). 574–581. 2 indexed citations

16.

Joshita, Satoru, Takeji Umemura, Yoko Usami, et al.. (2018). Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis. Scientific Reports. 8(1). 8159–8159. 27 indexed citations

17.

Yamazaki, Tomoo, Satoru Joshita, Takeji Umemura, et al.. (2018). Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(4). e0195632–e0195632. 13 indexed citations

18.

Umemura, Takeji, Tomoo Yamazaki, Satoru Joshita, et al.. (2018). Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C. Cytokine. 111. 357–363. 4 indexed citations

19.

Joshita, Satoru, Yuki Ichikawa, Takeji Umemura, et al.. (2017). Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatology Research. 48(4). 275–285. 31 indexed citations

20.

Shibata, Soichiro, Satoru Joshita, Takeji Umemura, et al.. (2016). Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. SpringerPlus. 5(1). 998–998. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact